<h1>Artemis Medicare Services Approves Hospital Expansion Plans and Releases Quarter 1 Financial Results</h1>
Artemis Medicare Services Limited announced that its Board of Directors approved both the unaudited financial results for the quarter ended June 30, 2026, and a significant expansion plan for its flagship hospital in Gurugram. The board meeting was held on August 3, 2026.
The company plans to execute a major capacity addition at its Sector-51, Gurugram hospital by adding over 200 beds to Tower IV. This expansion is focused on strengthening quaternary pediatric care and advanced gynecology and women's health services. The project is estimated to require an investment ranging from Rs. 160 to 180 Crore and is scheduled for completion within approximately two years, with funding secured through internal accruals and debt financing.
In addition to operational updates, the Board approved the unaudited financial results of both the company and the consolidated group for the quarter ending June 30, 2026.
Standalone Financial Performance (Quarter Ended June 30, 2026)
The standalone financial results show the performance of the Company during the first quarter of FY27. Key metrics include Revenue from Operations and profitability indicators.| Metric | Quarter ended 30-Jun-26 (Unaudited) | Quarter ended 31-Mar-26 (Audited) | Quarter ended 30-Jun-25 (Unaudited) | Year ended 31-Mar-26 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 28,200.97 | 27,378.66 | 24,979.86 | 1,06,049.17 |
| Other Income | 539.58 | 767.57 | 695.76 | 2,990.48 |
| Total Income | 28,740.55 | 28,146.23 | 25,675.62 | 1,09,039.65 |
| Total Expenses | 24,529.57 | 24,218.57 | 22,668.91 | 94,863.76 |
| Net Profit after Tax | 3,105.11 | 2,954.70 | 1,41.72 | 10,344.15 |
Consolidated Financial Performance (Quarter Ended June 30, 2026)
The consolidated results, which include the performance of the holding company and its subsidiary, Artemis Cardiac Care Private Limited, show the group's financial health for the quarter.| Metric | Quarter ended 30-Jun-26 (Unaudited) | Quarter ended 31-Mar-26 (Audited) | Quarter ended 30-Jun-25 (Unaudited) | Year ended 31-Mar-26 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 28,732.35 | 27,922.64 | 25,496.09 | 1,08,124.24 |
| Total Income | 29,269.74 | 28,701.32 | 26,188.88 | 1,11,107.16 |
| Total Expenses | 25,006.70 | 24,676.09 | 23,210.44 | 96,881.94 |
| Net Profit after Tax | 3,144.27 | 3,028.10 | 2,119.75 | 10,371.52 |
Additional Financial and Operational Details
The company’s operations are primarily focused on providing Healthcare Services, which is the sole reportable business segment across both standalone and consolidated results. The geographical revenue breakdown reflects a strong presence in India for Q1 FY27, with India contributing 20,550.45 (Lacs) to Revenue from Operations against a total of 28,200.97 (Lacs).Prior investment details revealed that the company had previously received 33,000 CCDs aggregating approximately 33,000 lacs from International Finance Corporation in April/May 2024. Of the proceeds from this issue, U5,434 lacs have been utilized toward expansion, with the remaining amount held in fixed deposits.
ARTEMISMED Stock Price Movement
Shares of Artemis Medicare Services Limited gained 1.21% today, edging higher to close at ₹302.2 after trading finished in the post-market session. The equity posted a strong performance, hitting an intraday high of ₹305 and reflecting robust investor interest throughout the day's 261,601 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: